WAY-208466

WAY-208466 is a drug that acts as a potent and selective agonist for the serotonin 5-HT6 receptor. It has been researched for its potential use in the treatment of cognitive disorders such as Alzheimer's disease and schizophrenia, but as of 2010, it has not been developed for medical use.

Pharmacology

WAY-208466 is a potent and selective agonist for the 5-HT6 receptor, a subtype of serotonin receptor. The 5-HT6 receptor is primarily found in the brain, and it is thought to play a role in cognitive function. Agonists of this receptor, such as WAY-208466, have been shown to enhance cognitive performance in animal models.

Potential Medical Uses

Research has suggested that 5-HT6 receptor agonists like WAY-208466 could have potential uses in the treatment of cognitive disorders. These could include conditions such as Alzheimer's disease and schizophrenia, where cognitive function is often impaired. However, as of 2010, WAY-208466 has not been developed for medical use.

Development Status

As of 2010, WAY-208466 has not been developed for medical use. It has been researched in preclinical studies, but it has not been tested in humans. The reasons for this are not clear, but it may be due to difficulties in drug development, such as problems with safety or efficacy.

See Also

• 5-HT6 receptor
• Serotonin
• Agonist
• Alzheimer's disease
• Schizophrenia

WAY-208466 Resources
Latest articles Most recent articles Ongoing trials	Wikipedia